Oct 15, 2026 09:20AM
Oct 13, 2026 09:02AM
Oct 13, 2026 09:01AM
Dec 30, 2025 09:15AM
Dec 30, 2025 09:15AM
Sep 17, 2025 08:45AM
Sep 17, 2025 08:45AM Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
Sep 9, 2025 06:53AM
May 15, 2025 08:05AM
Apr 16, 2025 08:00AM
Mar 20, 2025 08:35AM
Mar 20, 2025 08:35AM
Mar 3, 2025 09:02AM
Mar 3, 2025 09:00AM Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
Feb 19, 2025 09:00AM
Feb 3, 2025 08:00AM
Feb 3, 2025 08:00AM
Dec 18, 2024 08:53AM
Dec 18, 2024 08:51AM
Dec 16, 2024 09:06AM
Dec 16, 2024 09:05AM Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
Nov 19, 2024 08:02AM
Nov 19, 2024 08:00AM
Nov 14, 2024 04:15PM
Nov 8, 2024 08:00AM
Nov 8, 2024 08:00AM
Oct 15, 2024 08:00AM
Sep 17, 2024 08:01AM Akari Therapeutcis (AKTX): Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
Sep 17, 2024 08:00AM
Aug 19, 2024 04:15PM
Aug 19, 2024 08:00AM
Jun 5, 2024 08:00AM
Jun 4, 2024 08:01AM
Jun 4, 2024 08:00AM
May 16, 2024 08:00AM Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
May 1, 2024 08:01AM
May 1, 2024 08:01AM
May 1, 2024 08:00AM
Apr 15, 2024 08:00AM
Apr 1, 2024 06:30AM
Mar 11, 2024 05:26PM
Mar 8, 2024 04:38PM Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm
Mar 5, 2024 08:05AM
Mar 5, 2024 08:00AM
Mar 5, 2024 08:00AM
Aug 2, 2023 08:00AM
May 16, 2023 04:05PM
May 1, 2023 08:00AM
May 1, 2023 08:00AM Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights
Sep 27, 2022 08:00AM

1,199,254 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All